Novel Anti-Interleukin-1β Therapy Preserves Retinal Integrity: A Longitudinal Investigation Using OCT Imaging and Automated Retinal Segmentation in Small Rodents

Retinopathy of prematurity (ROP) is the leading cause of blindness in neonates. Inflammation, in particular interleukin-1β (IL-1β), is increased in early stages of the disorder, and contributes to inner and outer retinal vasoobliteration in the oxygen-induced retinopathy (OIR) model of ROP. A small...

Full description

Saved in:
Bibliographic Details
Main Authors: Diane N. Sayah (Author), Tianwei E. Zhou (Author), Samy Omri (Author), Javier Mazzaferri (Author), Christiane Quiniou (Author), Maëlle Wirth (Author), France Côté (Author), Rabah Dabouz (Author), Michel Desjarlais (Author), Santiago Costantino (Author), Sylvain Chemtob (Author)
Format: Book
Published: Frontiers Media S.A., 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_517d3ff6c4aa43ef846cb4aa5a9b4ca5
042 |a dc 
100 1 0 |a Diane N. Sayah  |e author 
700 1 0 |a Diane N. Sayah  |e author 
700 1 0 |a Tianwei E. Zhou  |e author 
700 1 0 |a Tianwei E. Zhou  |e author 
700 1 0 |a Tianwei E. Zhou  |e author 
700 1 0 |a Samy Omri  |e author 
700 1 0 |a Samy Omri  |e author 
700 1 0 |a Javier Mazzaferri  |e author 
700 1 0 |a Christiane Quiniou  |e author 
700 1 0 |a Maëlle Wirth  |e author 
700 1 0 |a Maëlle Wirth  |e author 
700 1 0 |a France Côté  |e author 
700 1 0 |a France Côté  |e author 
700 1 0 |a Rabah Dabouz  |e author 
700 1 0 |a Rabah Dabouz  |e author 
700 1 0 |a Rabah Dabouz  |e author 
700 1 0 |a Michel Desjarlais  |e author 
700 1 0 |a Michel Desjarlais  |e author 
700 1 0 |a Santiago Costantino  |e author 
700 1 0 |a Santiago Costantino  |e author 
700 1 0 |a Sylvain Chemtob  |e author 
700 1 0 |a Sylvain Chemtob  |e author 
700 1 0 |a Sylvain Chemtob  |e author 
245 0 0 |a Novel Anti-Interleukin-1β Therapy Preserves Retinal Integrity: A Longitudinal Investigation Using OCT Imaging and Automated Retinal Segmentation in Small Rodents 
260 |b Frontiers Media S.A.,   |c 2020-03-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2020.00296 
520 |a Retinopathy of prematurity (ROP) is the leading cause of blindness in neonates. Inflammation, in particular interleukin-1β (IL-1β), is increased in early stages of the disorder, and contributes to inner and outer retinal vasoobliteration in the oxygen-induced retinopathy (OIR) model of ROP. A small peptide antagonist of IL-1 receptor, composed of the amino acid sequence, rytvela, has been shown to exert beneficial anti-inflammatory effects without compromising immunovigilance-related NF-κB in reproductive tissues. We conducted a longitudinal study to determine the efficacy of "rytvela" in preserving the integrity of the retina in OIR model, using optical coherence tomography (OCT) which provides high-resolution cross-sectional imaging of ocular structures in vivo. Sprague-Dawley rats subjected to OIR and treated or not with "rytvela" were compared to IL-1 receptor antagonist (Kineret). OCT imaging and custom automated segmentation algorithm used to measure retinal thickness (RT) were obtained at P14 and P30; gold-standard immunohistochemistry (IHC) was used to confirm retinal anatomical changes. OCT revealed significant retinal thinning in untreated animals by P30, confirmed by IHC; these changes were coherently associated with increased apoptosis. Both rytvela and Kineret subsided apoptosis and preserved RT. As anticipated, Kineret diminished both SAPK/JNK and NF-κB axes, whereas rytvela selectively abated the former which resulted in preserved monocyte phagocytic function. Altogether, OCT imaging with automated segmentation is a reliable non-invasive approach to study longitudinally retinal pathology in small animal models of retinopathy. 
546 |a EN 
690 |a rytvela 
690 |a kineret 
690 |a anti-interleukin-1β 
690 |a therapy 
690 |a oxygen-induced retinopathy 
690 |a retina 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 11 (2020) 
787 0 |n https://www.frontiersin.org/article/10.3389/fphar.2020.00296/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/517d3ff6c4aa43ef846cb4aa5a9b4ca5  |z Connect to this object online.